Alport syndrome from bench to bedside: the potential of current treatment beyond RAAS blockade and the horizon of future therapies

O Gross, L Perin, C Deltas - Nephrology Dialysis …, 2014 - academic.oup.com
The hereditary type IV collagen disease Alport syndrome (AS) always leads to end-stage
renal failure. Yesterday, for the past 90 years, this course was described as 'inevitable' …
被引用次数：63 相关文章

Alport syndrome from bench to bedside: The potential of current treatment beyond RAAS blockade and the horizon of future therapies

O Gross, L Perin, CD Constantinou-Deltas - 2014 - gnosis.library.ucy.ac.cy
and (vi) secondary events such as infections, hyperparathyroidism and
hypercholesterolaemia. Therefore, moderate lifestyle, therapy of bacterial infections …

[引用][C] Alport syndrome from bench to bedside: the potential of current treatment beyond RAAS blockade and the horizon of future therapies

O Gross, L Perin, C Deltas - 2014 - publications.goettingen-research …
[PDF] academia.edu

[PDF][PDF] Full Review Alport syndrome from bench to bedside: the potential of current treatment beyond RAAS blockade and the horizon of future therapies

O Gross, L Perin, C Deltas - 2014 - academia.edu
The hereditary type IV collagen disease Alport syndrome (AS) always leads to end-stage
renal failure. Yesterday, for the past 90 years, this course was described as 'inevitable' …

Alport syndrome from bench to bedside: the potential of current treatment beyond RAAS blockade and the horizon of future therapies.

O Gross, L Perin, C Deltas - Nephrology Dialysis …, 2014 - search.ebscohost.com
The hereditary type IV collagen disease Alport syndrome (AS) always leads to end-stage
renal failure. Yesterday, for the past 90 years, this course was described as 'inevitable' …

[引用][C] Alport syndrome from bench to bedside: the potential of current treatment beyond RAAS blockade and the horizon of future therapies

O Gross, L Perin, C Deltas - Nephrology Dialysis Transplantation, 2014 - cir.nii.ac.jp
Alport syndrome from bench to bedside: the potential of current treatment beyond RAAS
blockade and the horizon of future therapies | CiNii Research CiNii 国立情報学研究所 学術情報 …

Alport syndrome from bench to bedside: the potential of current treatment beyond RAAS blockade and the horizon of future therapies.

O Gross, L Perin, C Deltas - Nephrology, Dialysis, Transplantation …, 2014 - europepmc.org
The hereditary type IV collagen disease Alport syndrome (AS) always leads to end-stage
renal failure. Yesterday, for the past 90 years, this course was described as' inevitable' …
[PDF] archive.org

[PDF][PDF] Full Review Alport syndrome from bench to bedside: the potential of current treatment beyond RAAS blockade and the horizon of future therapies

O Gross, L Perin, C Deltas - 2014 - scholar.archive.org
The hereditary type IV collagen disease Alport syndrome (AS) always leads to end-stage
renal failure. Yesterday, for the past 90 years, this course was described as 'inevitable' …
[PDF] researchgate.net

[PDF][PDF] Full Review Alport syndrome from bench to bedside: the potential of current treatment beyond RAAS blockade and the horizon of future therapies

O Gross, L Perin, C Deltas - 2014 - researchgate.net
The hereditary type IV collagen disease Alport syndrome (AS) always leads to end-stage
renal failure. Yesterday, for the past 90 years, this course was described as 'inevitable' …

Alport syndrome from bench to bedside: the potential of current treatment beyond RAAS blockade and the horizon of future therapies

O Gross, L Perin, C Deltas - … : official publication of the …, 2014 - pubmed.ncbi.nlm.nih.gov
The hereditary type IV collagen disease Alport syndrome (AS) always leads to end-stage
renal failure. Yesterday, for the past 90 years, this course was described as' inevitable' …